Xanthogranuloma, Juvenile
Showing 1 - 25 of 502
Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG), Rosai-Dorfman Disease (RDD) Trial (Mirdametinib)
Not yet recruiting
- Langerhans Cell Histiocytosis (LCH)
- +3 more
- (no location specified)
Nov 22, 2023
Rare Histiocytic Disorders (RHDs), Juvenile Xanthogranuloma (JXG), Reticulohistiocytoma (Epithelioid Histiocytoma) Trial in
Active, not recruiting
- Rare Histiocytic Disorders (RHDs)
- +7 more
- Registry study
-
Los Angeles, California
- +13 more
Dec 13, 2022
Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in
Recruiting
- Advanced Malignant Solid Neoplasm
- +44 more
- Biopsy
- +23 more
-
Birmingham, Alabama
- +166 more
Feb 2, 2023
Histiocytosis Trial in Beijing (68Ga-FAPI)
Not yet recruiting
- Histiocytosis
- 68Ga-FAPI
-
Beijing, ChinaDepartment of Nuclear Medicine, Peking Union Medical College Hop
Mar 25, 2023
Craniopharyngioma, Obesity Trial in Oldenburg
Recruiting
- Craniopharyngioma
- Obesity
-
Oldenburg, Niedersachsen, GermanyKlinikum Oldenburg
Mar 29, 2022
Juvenile Systemic Lupus Erythematosus
Recruiting
- Systemic Lupus Erythematosus
- lipid profile
-
Assiut, EgyptAssiut university
Nov 21, 2023
Severity in Juvenile and Adult-onset Dermatomyositis
Not yet recruiting
- Dermatomyositis
- evaluation of clinical severity
- (no location specified)
Aug 16, 2023
Fibrinogen to Albumin Ratio and C-reactive Protein to Albumin
Not yet recruiting
- Juvenile Idiopathic Arthritis
- fibrinogen to albumin ratio (AFR) and C-reactive protein to albumin ratio (CAR)
- (no location specified)
Aug 29, 2023
Active Systemic Juvenile Idiopathic Arthritis Trial in China (GenaKumab)
Not yet recruiting
- Active Systemic Juvenile Idiopathic Arthritis
-
Beijing, Benjing, China
- +9 more
Jul 5, 2023
Juvenile Idiopathic Arthritis Trial in Al Kharj (Accommodating variable-resistance training, Standard physical therapy)
Completed
- Juvenile Idiopathic Arthritis
- Accommodating variable-resistance training
- Standard physical therapy
-
Al Kharj, Riyadh, Saudi ArabiaRagab K. Elnaggar
Mar 28, 2023
Adenosine Deaminase and Immunoglobulin E in Chronic Spontaneous
Not yet recruiting
- Chronic Spontaneous Urticaria
- Adenosine deaminase serum level
- IgE antibodies serum level
- (no location specified)
Aug 7, 2023
Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset Trial in Japan (Anakinra, Placebo)
Recruiting
- Still's Disease, Juvenile Onset
- Still's Disease, Adult-Onset
- Anakinra
- Placebo
-
Chiba-shi, Chiba, Japan
- +17 more
Apr 3, 2023
Plexin D1 as a Potential Biomarker inPM/DM
Not yet recruiting
- Polymyositis
- Dermatomyositis
- plexinD1
- (no location specified)
Nov 25, 2022
Juvenile Recurrent Respiratory Papillomatosis: Establishment
Recruiting
- Juvenile Recurrent Respiratory Papillomatosis
-
Paris, Francehôpital Necker Enfants malades
Aug 17, 2023
Neurodevelopmental Disorders in Youth With Criminal Behaviors
Completed
- Attention Deficit Disorder With Hyperactivity
- +2 more
- collect data
-
Taipei, TaiwanNational Taiwan University Hospital
May 23, 2023
Active Juvenile Psoriatic Arthritis Trial in Worldwide (Apremilast, Placebo)
Recruiting
- Active Juvenile Psoriatic Arthritis
- Apremilast
- Placebo
-
Bregenz, Austria
- +36 more
Feb 1, 2023
Spondylarthropathies Trial in Nîmes, Montpellier (Stool collection at the patient's home., Blood test)
Recruiting
- Spondylarthropathies
- Stool collection at the patient's home.
- Blood test
-
Nîmes, Gard, France
- +1 more
Jul 27, 2022
Adult and Juvenile Myositis
Recruiting
- Dermatomyositis
- +2 more
-
Bethesda, Maryland
- +1 more
Jan 20, 2023
Childhood Absence Epilepsy, Juvenile Absence Epilepsy Trial in Worldwide (Brivaracetam Film-coated tablet, Brivaracetam oral
Enrolling by invitation
- Childhood Absence Epilepsy
- Juvenile Absence Epilepsy
- Brivaracetam Film-coated tablet
- Brivaracetam oral solution
-
Birmingham, Alabama
- +21 more
Jan 5, 2023
Leukemia, Juvenile Myelomonocytic, JMML, JCML Trial (Trametinib, Azacitidine, Fludarabine)
Not yet recruiting
- Leukemia, Juvenile Myelomonocytic
- +4 more
- Trametinib
- +3 more
- (no location specified)
May 4, 2023
Systemic Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)
Recruiting
- Systemic Juvenile Idiopathic Arthritis
- Baricitinib
- Placebo
-
Rosario, Santa Fe, Argentina
- +65 more
Jan 18, 2023
Polyarticular-course Juvenile Idiopathic Arthritis (JIA) Trial in Worldwide (Certolizumab Pegol (CZP))
Active, not recruiting
- Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
- Certolizumab Pegol (CZP)
-
Little Rock, Arkansas
- +35 more
Dec 1, 2022